ABCC7 p.Asp1152Ala

ClinVar: c.3454G>C , p.Asp1152His D , Pathogenic
CF databases: c.3454G>C , p.Asp1152His ? , Varying clinical consequence ; CFTR1: The family in whom this mutation was identified is of Ashkenazi/Jewish/North European Protestant and is remarkable for advanced age, mild pulmonary disease, pancreatic sufficiency and normal sweat chloride values. The index patient was diagnosed with variant CF at the age of 57 on the basis of clinical phenotype and abnormal nasal epithelial bioelectric parameters.
Predicted by SNAP2: A: D (80%), C: D (85%), E: D (66%), F: D (85%), G: D (91%), H: D (66%), I: D (91%), K: D (91%), L: D (91%), M: D (85%), N: D (80%), P: D (95%), Q: D (80%), R: D (91%), S: D (80%), T: D (75%), V: D (91%), W: D (95%), Y: D (91%),
Predicted by PROVEAN: A: D, C: D, E: N, F: D, G: D, H: D, I: D, K: N, L: D, M: D, N: N, P: D, Q: N, R: D, S: N, T: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Cui G, Song B, Turki HW, McCarty NA
Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.
Pflugers Arch. 2012 Mar;463(3):405-18. Epub 2011 Dec 13., [PMID:22160394]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Cui G, Freeman CS, Knotts T, Prince CZ, Kuang C, McCarty NA
Two salt bridges differentially contribute to the maintenance of cystic fibrosis transmembrane conductance regulator (CFTR) channel function.
J Biol Chem. 2013 Jul 12;288(28):20758-67. doi: 10.1074/jbc.M113.476226. Epub 2013 May 24., [PMID:23709221]

Abstract [show]
Comments [show]
Sentences [show]